Drug
Kk8398
Kk8398: highest development phase Phase 3, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KK8398 NCT06926491 | Phase 3 | Achondroplasia |
Latest
No recent events.
Follow Kk8398 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.